Search results
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 1 hour agoNegative Points Despite overall strong performance, Enbrel sales decreased by 2% year-over-year in the first quarter, driven by volume decline. The company's non-GAAP operating ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters via AOL· 13 hours ago(Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its...
Amgen First-Quarter Profit Dips 1%, Revenue Rises 22%
US News & World Report· 13 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Zacks via Yahoo Finance· 11 hours agoThe headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
Zacks via Yahoo Finance· 4 days agoGet a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended March 2024...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 4 days agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 2 days agoVyndaqel family sales beat the Zacks Consensus Estimate of $952.0 million as well as our model...
Amgen's Options: A Look at What the Big Money is Thinking - Amgen (NASDAQ:AMGN)
Benzinga· 16 hours agoFlagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...
What to Watch in the Day Ahead - Thursday, May 2
Reuters via Yahoo Finance· 2 days agoInvestors will expect commentary on how it plans to revive sales and updates on AI development, which is driving gains at Big Tech peers. Moderna is expected report first-quarter earnings, as ...